Yoshikawa T, Yoshida N, Hosoki K
Department of Pharmacology, Dainippon Pharmaceutical Co., Ltd., Suita/Osaka, Japan.
Eur J Pharmacol. 1996 Apr 22;301(1-3):143-9. doi: 10.1016/0014-2999(96)00061-1.
We investigated the possible involvement of dopamine D3 receptors in R(+)-7-hydroxy-2-(N,N-di-n-propylamino)tetraline (R(+)-7-OH-DPAT)-induced emesis in the ferret. The R(+)enantiomer of 7-OH-DPAT (0.03-1 mg/kg, s.c.) caused emesis in a dose-dependent manner, whereas the S(-)enantiomer, even at 1 mg/kg s.c. failed to induce emesis. Quinpirole (0.1-1.0 mg/kg) and apomorphine (0.3 mg/kg, s.c. only) also elicited an emetic response. S(-)-Eticlopride, which has a high affinity for the dopamine D3 receptor, antagonized R(+)-7-OH-DPAT (0.3 mg/kg, s.c.)-induced emesis (ID50 1.4 micrograms/kg, s.c.). R(+)-7-OH-DPAT (0.1-1.0 microgram) administered into the 4th cerebral ventricle dose dependently induced emesis within 1 min of dosing in ferrets. Intracerebroventricularly administered S(-)-eticlopride (0.01-1 microgram) also inhibited the emesis induced by s.c. administration of R(+)-7-OH-DPAT. The emetic effect of R(+)-7-OH-DPAT was unaffected by abdominal vagotomy but was markedly reduced by ablation of the area postrema. These results suggest that dopamine D3 receptors in the area postrema play an important role in R(+)-7-OH-DPAT-induced emesis in the ferret.
我们研究了多巴胺D3受体在R(+)-7-羟基-2-(N,N-二正丙基氨基)四氢萘(R(+)-7-OH-DPAT)诱导雪貂呕吐中可能发挥的作用。7-OH-DPAT的R(+)对映体(0.03-1mg/kg,皮下注射)以剂量依赖性方式引起呕吐,而S(-)对映体即使皮下注射1mg/kg也未能诱导呕吐。喹吡罗(0.1-1.0mg/kg)和阿扑吗啡(仅皮下注射0.3mg/kg)也引发呕吐反应。对多巴胺D3受体具有高亲和力的S(-)-依托必利拮抗R(+)-7-OH-DPAT(0.3mg/kg,皮下注射)诱导的呕吐(半数抑制剂量为1.4μg/kg,皮下注射)。向雪貂第四脑室注射R(+)-7-OH-DPAT(0.1-1.0μg)在给药后1分钟内剂量依赖性地诱导呕吐。脑室内注射S(-)-依托必利(0.01-1μg)也抑制皮下注射R(+)-7-OH-DPAT诱导的呕吐。R(+)-7-OH-DPAT的催吐作用不受腹部迷走神经切断术的影响,但最后区切除后明显减弱。这些结果表明,最后区的多巴胺D3受体在R(+)-7-OH-DPAT诱导雪貂呕吐中起重要作用。